Ignite Creation Date:
2025-12-24 @ 9:12 PM
Ignite Modification Date:
2025-12-24 @ 9:12 PM
Study NCT ID:
NCT05244304
Status:
COMPLETED
Last Update Posted:
2025-10-31
First Post:
2022-01-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease
Sponsor:
Belite Bio, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-28
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-20
First Submit QC Date:
None
Study First Post Date:
2022-02-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-30
Last Update Post Date:
2025-10-31
Last Update Post Date Type:
ESTIMATED